One cycle is a single round of the ovary preparing a follicle, releasing an egg, and then running a roughly two week hormone phase before the sequence resets. Four phases describe that sequence, the menstrual phase, the follicular phase, the ovulatory phase and the luteal phase.
The control chain starts in the brain. The hypothalamus releases gonadotropin releasing hormone in pulses, the pituitary answers with follicle stimulating hormone (FSH) and luteinising hormone (LH), and the ovary answers those signals with Estradiol and progesterone. The ovary then talks back, so the same hormone can restrain the brain's signal at one point in the cycle and drive it at another. Research suggests that this switch in estradiol feedback, from restraining the pituitary to stimulating it, is what allows the mid cycle LH surge to occur at all 1.
Underneath the hormone curve, two things change in parallel. In the ovary, a group of follicles is recruited, one becomes dominant, and after release the emptied follicle becomes the corpus luteum, a temporary hormone producing structure. In the uterus, the lining sheds, rebuilds, and then shifts into a secretory state before it either stays or sheds again.
That is why phase language is more useful than a date. Saying day 19 means little on its own. Saying mid luteal tells a clinician which hormones should be high, which should be low, and what a lab value is being compared against. It also explains why the same blood test, drawn two weeks apart, can produce two very different numbers in the same healthy person without anything having gone wrong.
Estradiol is the main estrogen produced by the developing follicle, measured with a standard blood draw and reported in picograms per millilitre (pg/mL). Because it moves so much across the cycle, it is the clearest single read on where a cycle currently sits. The biomarker page on estradiol covers what the marker does, how it is tested and how to read a result in more detail.
In brief, typical lab reference ranges run roughly 15 to 500 pg/mL in women across a full cycle and roughly 10 to 40 pg/mL in men. Ranges vary by lab, assay, age and sex. FitScript's optimal range is 30 to 400 pg/mL for women and 20 to 35 pg/mL for men. Optimal ranges are optimization targets, not diagnostic cut-offs, and any single value is read alongside cycle day, symptoms and other markers.
Day 1 is the first day of real bleeding, not the day of light spotting that sometimes comes before it. Everything else in the cycle is counted from there, so getting day 1 right is the difference between a result that can be interpreted and one that cannot.
The 28 day cycle is a textbook average rather than a standard. Healthy cycles run shorter and longer than that, and the same person's cycles vary from month to month, particularly in the years after periods first start and in the years approaching menopause. Most of that variation sits in the follicular phase, which can stretch or shorten depending on how quickly a dominant follicle matures. The luteal phase is comparatively consistent in length.
That asymmetry has a practical consequence. Studies indicate that counting days forward from the start of bleeding is an unreliable way to identify phase in cycles of variable length, and that anchoring to ovulation, confirmed with urinary LH testing or a mid luteal progesterone measurement, or counting backward from the start of the next period, places a sample in its phase far more accurately 2.
So if you are tracking your cycle for the sake of making lab results interpretable, record two things. Record the date bleeding started, and record the date the next period started. Those two anchors let a clinician place any blood draw between them.
The menstrual phase is when the uterine lining built in the previous cycle is shed, and it is the one phase of the cycle you can see. It occupies the first days of the cycle, and for most people it is over within a week.
Hormonally, this is the floor of the curve. Estradiol and progesterone are both at or near their lowest, because the corpus luteum from the previous cycle has stopped producing them. That withdrawal is what triggers the shedding in the first place. With estradiol low, its restraining effect on the pituitary lifts, and FSH begins to rise again, which is already the start of the next follicular phase. The phases overlap at the edges.
Two practical points sit here. First, this low hormone window is the conventional time for baseline pituitary and ovarian testing, because values are least affected by a dominant follicle. Second, repeated monthly blood loss draws on iron stores, which is why ferritin and a full blood count are often looked at in people with heavy or prolonged bleeding.
If flow is heavy enough to soak through protection hourly, lasts beyond a week, or comes with clots and exhaustion, that pattern is worth discussing with a clinician promptly rather than tracking for another few months.
The follicular phase is the rebuilding half of the cycle, when FSH recruits a group of follicles in the ovary and estradiol climbs steadily as one of them takes over. It starts on day 1, overlapping the bleed, and ends at ovulation.
Early on, FSH is relatively high and a cohort of small follicles begins to grow. As those follicles produce estradiol, the rising estradiol feeds back on the pituitary and pulls FSH down again, which withdraws support from all but the most responsive follicle. That one becomes dominant and keeps growing while the others regress. Research suggests that this interplay of FSH availability and follicular estradiol output is the selection mechanism that normally leaves a single dominant follicle 1.
Meanwhile the uterine lining responds to the climbing estradiol by thickening. Cervical mucus changes character. Many people notice energy and mood feel steadier through the late follicular phase, though this varies widely between individuals.
For testing, the key point is that estradiol in the late follicular phase can be many times what it was on day 3 in the same person. A result that looks high against a generic range may be entirely expected for the day it was drawn, and a result that looks reassuringly mid range may be unexpectedly low for a late follicular sample. The day is part of the result.
The ovulatory phase is the short window around the LH surge, when the dominant follicle ruptures and releases an egg. It is the briefest of the four phases, usually measured in hours to a couple of days rather than a week.
The trigger is the feedback switch described above. Once estradiol has been high for long enough, it stops suppressing the pituitary and starts driving it, producing a sharp LH surge with a smaller accompanying FSH rise. Research suggests that the duration and height of the estradiol signal, not just its peak value, determine whether this positive feedback is reached 1. Within roughly a day of the surge, the follicle ruptures.
Estradiol falls back from its peak around the same time, and progesterone, which has been low all cycle, begins to rise as the ruptured follicle reorganises into the corpus luteum.
This is also the phase that causes the most confusion on lab reports. A sample drawn in this narrow window can catch estradiol at a peak, mid fall or already low, and LH at surge level or baseline, all within two days. If a result looks inconsistent with everything around it, the first question is usually whether the draw landed near ovulation rather than whether something is wrong.
The luteal phase runs from ovulation to the start of the next period, and it is the only phase in which progesterone is the dominant hormone. The corpus luteum produces it, along with a second, smaller rise in estradiol, giving the luteal phase its characteristic two hormone profile.
Progesterone converts the thickened uterine lining into a secretory state, raises resting body temperature slightly, and acts on the brain through its metabolites. If no pregnancy occurs, the corpus luteum has a limited lifespan and regresses, both hormones drop, and that withdrawal starts the next bleed. Research suggests that the corpus luteum's output, and its timely regression, are what set the length and the closing hormone pattern of this phase 1.
The late luteal phase, the few days before bleeding starts, is when premenstrual symptoms cluster. Sleep, mood, appetite, bloating, breast tenderness and headache are the common reports, and their intensity varies enormously between people and between cycles.
For testing, the mid luteal phase is where progesterone is conventionally measured, because that is when it should be at its highest. A low mid luteal progesterone may reflect a sample taken on the wrong day as easily as it may reflect a cycle that did not ovulate, which is why the result is interpreted with the cycle record in hand.
The hormone curve has a predictable shape, one estradiol peak before ovulation, one progesterone peak after it, and an LH spike in between. The table below shows the direction of travel for each marker in each phase.
| Phase | Roughly when | Estradiol | Progesterone | LH and FSH | Ovary and lining |
|---|---|---|---|---|---|
| Menstrual | Day 1 to end of bleeding | Lowest | Lowest | FSH rising, LH low | Lining shedding, new follicles recruited |
| Early to mid follicular | After bleeding ends | Rising | Low | FSH falling as estradiol rises | Dominant follicle selected, lining rebuilding |
| Late follicular | Days before ovulation | Peak of the cycle | Low | LH climbing | Dominant follicle mature, lining thickened |
| Ovulatory | Around the LH surge | Falling from peak | Starting to rise | LH surge, smaller FSH rise | Follicle ruptures, egg released |
| Early to mid luteal | After ovulation | Second, smaller rise | Peak of the cycle | Both low | Corpus luteum active, lining secretory |
| Late luteal | Few days before next period | Falling | Falling | Beginning to rise | Corpus luteum regressing |
This table describes the shape of the curve, not reference ranges. Actual values differ by lab, assay, age and sex, and the numeric ranges for any single marker belong on that marker's own page. What the shape gives you is a way to ask the right question about a result. Does this value match the phase it was drawn in, and if not, was the phase correctly identified in the first place?
Because estradiol and progesterone vary several fold within a single cycle, an undated hormone result is close to uninterpretable. The number is real, but the comparison it needs is missing.
Consider a single estradiol value sitting in the lower half of the standard range. Drawn on day 3, that is an ordinary baseline. Drawn two days before ovulation, the same number would be unexpected and would prompt a different conversation. Nothing about the blood changed, only the context.
The same logic applies in the other direction. A progesterone result near the floor is exactly what you would expect in the follicular phase and tells you almost nothing. The identical result seven days before the next period raises a question worth exploring with a clinician.
Studies indicate that cycle phase cannot be reliably inferred from calendar counting alone when cycles vary in length, and that verifying phase with a hormonal marker changes how samples should be grouped and interpreted 2. In practice that means a lab slip without a cycle day, or with a cycle day calculated from a guessed start date, weakens the result it is attached to.
The workable habit is simple. Log the first day of each period. When blood is drawn, write down which cycle day it is and when the previous period started, and note the next period's start date afterwards so the draw can be placed by counting backward too.
Timing conventions differ by marker, and the clinician ordering the test decides which window fits the question being asked. The general pattern is that pituitary and baseline ovarian markers are drawn early in the cycle, and progesterone is drawn in the mid luteal phase.
Baseline FSH, LH and estradiol are conventionally sampled in the early follicular phase, during the first days of bleeding, because that is when a dominant follicle is not yet distorting the picture. Progesterone is conventionally sampled in the mid luteal phase, roughly a week before the next period is expected, because that is when the corpus luteum should be at peak output. Studies indicate that a mid luteal progesterone measurement is one of the practical ways to confirm that ovulation occurred in a given cycle, which is also what makes the phase assignment trustworthy 2.
Some markers do not need cycle timing at all. Thyroid markers, prolactin, SHBG, DHEA sulfate and metabolic markers are generally less cycle dependent, though a clinician may still standardise the draw time of day.
In cycles that are highly irregular, or in people whose periods have stopped, counting days does not work. The clinician then chooses an approach, which may mean sampling on an arbitrary day and repeating, or using a different marker set entirely. Follow the laboratory's own preparation instructions, and keep repeat testing at the same lab where possible, because assays differ.
Sleep quality and the daily cortisol pattern both shift across the cycle, which matters for how you feel and for how certain results are read. Research suggests that sleep changes across menstrual cycle phases, with disturbance more commonly reported in the late luteal and premenstrual window 3.
The plausible contributors are the ones already described. Progesterone acts on the brain and body temperature through the luteal phase, and both it and estradiol fall sharply in the days before bleeding starts. Many people report that the nights immediately before a period are the lightest and most broken of the month, then that sleep settles once the bleed is underway.
Stress hormone measurement carries a similar caveat. Research suggests that the cortisol awakening response can vary with menstrual cycle phase, which means comparing a morning cortisol sample taken in one phase against one taken in another is not a like for like comparison 4.
The practical takeaway is about interpretation rather than action. If you are tracking sleep or a morning stress marker over months, note the cycle phase alongside each measurement. Otherwise a normal monthly rhythm can look like a trend, or a real trend can be hidden inside the monthly rhythm. Persistent insomnia, or premenstrual symptoms that disrupt work and relationships, are worth raising with a clinician rather than absorbing.
Mood shows clearer cycle linked variation than cognitive performance does. Research suggests that the menstrual cycle influences emotion more consistently than it influences cognitive function, where effects have been smaller and less uniform 6.
Two hormones carry most of the attention. Research suggests that estradiol and progesterone influence aspects of neurocognition across cycle phases, with the size and direction of the effect shaped by other individual factors rather than being uniform across people 5. That is consistent with a common observation, which is that two people with similar hormone curves report quite different premenstrual experiences.
There is also work on within person change rather than group averages. Research suggests that fluctuations in estradiol across the cycle track changes in affect and socioemotional functioning, meaning the size of a person's own hormonal swing carries information that an average value does not 7.
What this means practically is that a single mood questionnaire, or a single estradiol result, is a weak description of a cyclical pattern. Tracking symptoms daily for two or three full cycles alongside the dates of each period gives a far better picture of whether symptoms cluster in a particular phase. If they do, and if they are severe enough to interfere with daily life, that pattern is the thing to bring to a clinician. Any next step after that is a clinical decision, not a self directed one.
Cycle timing is set by a brain signal that is sensitive to the body's wider state, so a long list of ordinary things can lengthen, shorten or skip a cycle. The most common influences are age, energy availability, illness, major stressors and sleep disruption.
Age works at both ends. Cycles are often irregular in the first years after periods begin, settle through the reproductive years, and become variable again in the transition toward menopause as follicle numbers decline and estradiol output becomes erratic.
Energy availability is the next most common. Sustained low intake relative to training load, rapid weight change in either direction, and heavy exercise volumes can all lengthen cycles or stop them. Acute illness, a run of very short nights, shift work and significant psychological stress can delay ovulation in a single cycle, which shows up as a late period rather than a missed one.
There are also clinical causes that need a clinician to sort out, including thyroid dysfunction, elevated prolactin, polycystic ovary syndrome, and structural conditions of the uterus such as fibroids or polyps. In people with any of these, cycle changes are usually one sign among several.
One or two unusual cycles in a year is common. A persistent change in your own normal pattern, lasting three cycles or more, is the signal worth investigating rather than waiting out.
Estradiol alone describes one point on one curve, so it is usually ordered with the hormones that give it context and the markers that explain a disrupted cycle. The panel a clinician chooses depends on the question.
The immediate companions are progesterone, LH and FSH, which together place a sample in its phase and show whether the pituitary and ovary are responding to each other. Sex hormone binding globulin matters because it determines how much hormone is free and active. Total and free testosterone and DHEA sulfate are commonly added when cycles are long or absent, and prolactin is checked because it can suppress the cycle signal from above.
Thyroid function, usually TSH with free T4 and sometimes thyroid antibodies, sits close behind, because thyroid status and the menstrual cycle are tightly connected. Ferritin and a full blood count matter in anyone with heavy or prolonged bleeding. Fasting insulin, glucose and HbA1c are often reviewed where cycles are irregular, since metabolic and reproductive signalling overlap. Vitamin D and basic inflammatory markers round out a general picture.
This is the logic behind broad, repeated panels rather than single tests. A FitScript membership includes 150+ biomarkers tested per year, with results interpreted by Atlas, FitScript's AI health advisor, so a cycle marker is read next to thyroid, metabolic and iron data rather than in isolation.
Any persistent change from your own normal pattern deserves a conversation, and a few patterns deserve a prompt one. Bleeding heavy enough to soak through protection within an hour, bleeding that lasts beyond a week, bleeding between periods or after sex, severe pain that stops you functioning, and periods that have stopped for three months or more are all worth discussing with a clinician promptly.
The softer signals are worth raising too. Cycles that have become consistently much shorter or much longer, premenstrual symptoms that interfere with work, sleep or relationships, new symptoms that arrived alongside weight change or a change in training load, and hormone results that do not match the phase they were drawn in all belong in a clinical conversation rather than a tracking app.
Bring three things to that appointment. Bring the start dates of your last several periods, a short symptom log showing where in the cycle symptoms fall, and any lab results with the cycle day written on them. That combination answers most of the first round of questions a clinician will ask.
This page is educational and is not medical advice. Discuss your results, your symptoms and any next step with a clinician or licensed provider, because treatment decisions belong to a licensed provider who has reviewed your full picture.
They are the menstrual phase, which is the bleed, the follicular phase, when a follicle develops and the uterine lining rebuilds, the ovulatory phase, the short window when an egg is released, and the luteal phase, which runs until the next period starts. Each phase has its own hormone pattern. Some descriptions list only three phases because the bleed sits inside the follicular phase.
The bleed usually lasts a few days up to about a week. The follicular phase is the most variable and accounts for most of the difference in cycle length between people and between months. The ovulatory window is the shortest, measured in hours to a couple of days, and the luteal phase that follows is comparatively consistent in length.
Count from the first day of real bleeding, which is day 1, and compare that with how long your recent cycles have run. Counting alone is approximate when cycle length varies, so a clinician may confirm the phase with a hormone measurement instead. Logging the start date of every period makes this far more accurate over time.
Because estradiol and progesterone change several fold within one cycle, the same number can be entirely expected in one phase and unexpected in another. Without a cycle day, the result has no comparison to be judged against. Write the cycle day on the requisition and note when your previous period started.
Yes, and in a regular cycle that is exactly what should happen. Estradiol is at its lowest during the bleed, climbs through the follicular phase to a peak before ovulation, falls back, then rises again more modestly in the luteal phase. A clinician reads the value against the day it was drawn.
Some variation is common, particularly in the years after periods begin and in the years approaching menopause. Illness, very short nights, big stressors, travel and changes in training load or food intake can delay ovulation in a single cycle and push the period later. A persistent change from your own normal pattern over three cycles or more is worth raising with a clinician.
Record the first day of every period, how many days bleeding lasts, how heavy it is, and any symptoms with the date they occur. Bring that log to your appointment along with any lab results that have a cycle day written on them. In irregular or absent cycles, counting days does not reliably identify phase, so a clinician will choose how and when to test.
Contact a clinician promptly for bleeding heavy enough to soak through protection within an hour, bleeding lasting beyond a week, bleeding between periods or after sex, severe pain, or periods that have stopped for three months or more. Also raise cycles that have become consistently much shorter or longer, and premenstrual symptoms that interfere with daily life. Any next step is a clinical decision.